NextCure, Inc. (NXTC) Dividend History

NextCure, Inc. is a biopharmaceutical company focused on developing immuno-oncology therapies to treat cancer. Founded to leverage groundbreaking research in immunology, the company aims to discover and develop novel monoclonal antibodies that can modulate immune responses and improve outcomes for cancer patients.

9000 Virginia Manor Road, Suite 200, Beltsville, MD, 20705
Phone: 240-399-4900
Website: https://www.nextcure.com

Dividend History

NextCure, Inc. currently does not pay dividends

Company News

  • NextCure, a clinical-stage biopharmaceutical company, announced the completion of cohort 1 of the Phase 1 trial for its B7-H4 ADC drug candidate and plans to initiate backfill cohorts in the second half of 2025. The company reported a cash position of approximately $68.6 million.

    GlobeNewswire Inc.
  • Pyxis Oncology is developing antibodies and antibody-drug conjugates for various tumor types. See why PYXS stock is a Hold.

    Seeking Alpha
    Featured Companies: PYXS
  • NextCure, Inc. (NXTC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

    Zacks Investment Research
  • Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates. Amtech reported quarterly sales of $27.70 million, missing the analyst consensus estimate of $34.50 million. The company anticipated first-quarter revenue to be between $21 million and $24 million, versus the $34.15 million estimate. Benchmark analyst Mark Miller downgraded Amtech Systems from Buy to Hold. Amtech Systems shares fell 30.6% to $4.16 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares jumped 322% to $1.14 after the company announced Amazon Mexico renewed its selection of Fr8App for its logistical solutions. SRIVARU Holding Limited (NASDAQ: SVMH) rose 74.8% to $0.7000. XBP Europe Holdings, Inc. (NASDAQ: XBP) shares gained 49% to $8.46 after declining around 20% on Wednesday. TPI Composites, Inc. (NASDAQ: TPIC) rose 46% to $3.1350 as the company announced refinancing transaction with Oaktree, significantly strengthening company’s liquidity position and enhancing financial flexibility. Nxu, Inc. (NASDAQ: NXU) rose 43.6% to $0.0280 after the company signed a letter of intent outlining investment in Lynx Motors. Canterbury Park Holding Corporation (NASDAQ: CPHC) rose 31% to $18.70. View, Inc. (NASDAQ: VIEW) gained 29% to $5.14. Hanryu Holdings, Inc. (NASDAQ: HRYU) gained 27.1% to $1.3850 after jumping 28% on Wednesday. Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares climbed 23.2% to $1.8603. Esperion said that the FDA updated LDL-C lowering indication for NEXLETOL (bempedoic acid) tablet and NEXLIZET (bempedoic acid and ezetimibe) tablet. Redfin Corporation (NASDAQ: RDFN) gained 21.8% to $10.26. Codexis, Inc. (NASDAQ: CDXS) ...

    Benzinga
  • What happened in the stock market on Tuesday October 4 and what to watch with penny stocks this week The post What Happened In The Stock Market Today & 4 Penny Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: DNA MRK
Page data last updated 07/23/2025 21:14:30 UTC